 |
3-{3-[4-(1-aminocyclobutyl)phenyl]-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl}cpyridin-2-amine bis-mesylate |
|---|---|
| Trade Name | |
| Orphan Indication | Proteus syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2015-11-09 00:00:00 |
| Sponsor | ArQule, Inc.;One Wall Street;Burlington, Massachusetts, 01803 |
Related Access Program